C-Suite Regulatory Intelligence
Executive policy briefs.
أوراق السياسات والدراسات الاستراتيجية
Authoritative executive whitepapers and legal memoranda authored for multinational healthcare leadership teams entering the Saudi healthcare ecosystem.
Q3 2025 Edition28 Pages • Executive Whitepaper
Saudi Arabia Medical Device Market Access: Strategic Roadmap to 2030
Intended Readership: C-Suite, VP Regulatory Affairs & Managing Directors
Executive analysis of the evolving SFDA statutory landscape, NUPCO procurement priorities, and clinical trial regulations under Saudi Vision 2030.
Key Executive Takeaways in this Memorandum:
SFDA classification shifts for borderline combination devices
NUPCO centralized tender qualification prerequisites
Abridged review acceleration strategies using foreign reference CE/FDA data
Q2 2025 Edition18 Pages • Executive Whitepaper
Authorized Representative Rights: De-risking Foreign Distribution in KSA
Intended Readership: Chief Legal Counsel & Corporate Strategists
A corporate legal guide to unbundling marketing authorizations from commercial distribution contracts under Saudi commercial law and SFDA bylaws.
Key Executive Takeaways in this Memorandum:
Distributor lock-in mechanisms and legal liability traps
Contractual clauses ensuring unilateral license transferability
Sovereign legal structure for multi-distributor regional scaling
Q1 2025 Edition24 Pages • Executive Whitepaper
Software as a Medical Device (SaMD) & Health Cloud Compliance Guide
Intended Readership: Digital Health Innovators, CTOs & Compliance Officers
Navigating the intersection of SFDA MDS-G015 software regulations and Saudi National Cybersecurity Authority (NCA) data residency controls.
Key Executive Takeaways in this Memorandum:
IEC 62304 lifecycle documentation for cloud-hosted clinical algorithms
Saudi Health Cloud mandatory in-Kingdom server architecture
Clinical AI machine learning validation and bias documentation
Commission a Bespoke Regulatory Memorandum.
Our Senior Regulatory Directorate authors proprietary gap analyses, competitor approval roadmaps, and pricing feasibility studies for international manufacturers.